跳至主要内容
临床试验/NCT00161980
NCT00161980已完成3 期

A Randomized and Controlled Clinical Study to Evaluate the Efficacy and Safety of Fibrin Sealant VH S/D (FS VH S/D) in Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

Baxter Healthcare Corporation16 个研究点 分布在 4 个国家开始时间: 2001年6月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
试验地点
16

研究概览

简要总结

This study will monitor the safety of FS VH S/D and will evaluate whether FS VH S/D is superior to conventional surgical procedures in the reduction of lymphatic leakage by sealing the axillary lymphatics in subjects undergoing lumpectomy and level I and II axillary lymph node dissection with two separate incisions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Written informed consent has been obtained from the subject prior to FS VH S/D administration
  • Female subjects >= 19 years of age
  • Subjects with breast cancer scheduled to undergo lumpectomy of the breast and level I and II axillary lymphadenectomy with two separate incisions

排除标准

  • Subjects with known hypersensitivity to aprotinin or other components of the product
  • Subjects with immunodeficiency
  • Subjects with increased red cell production (e.g., in hemolytic anemia)
  • Subjects with coagulation disorders shown by exceeding the normal range of any of following: prothrombin time (PT), Quick, activated partial thromboplastin time (aPTT), fibrinogen level, or thrombocytes.
  • Subjects having previously had axillary surgery
  • Subjects having undergone irradiation therapy to the axillary tissue
  • Subjects having ever received chemotherapy before the surgery

研究者

申办方类型
Industry

研究点 (16)

Loading locations...

相似试验